Advanced search
Publication Cover
Substance Abuse and Rehabilitation Volume 2, 2011 - Issue
Submit an article Journal homepage
102
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: results from the clinical Trials Network

Daniel J Pilowsky1 Departments of Epidemiology and Psychiatry, Columbia University, and the New York State Psychiatric Institute, New York City, NYCorrespondence[email protected]
,
Li-Tzy Wu2 Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University Medical Center, Durham, NC
,
Bruce Burchett2 Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University Medical Center, Durham, NC
,
Dan G Blazer2 Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University Medical Center, Durham, NC
,
George E Woody3 Department of Psychiatry, School of Medicine, University of Pennsylvania and Treatment Research Institute, Philadelphia, PA
&
Walter Ling4 David Geffen School of Medicine, NPI/Integrated Substance Abuse Programs, University of California, Los Angeles, CA, USA
Pages 133-144 | Published online: 27 Jul 2011

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Andrea G. Barthwell, Jeffrey Allgaier & Kenneth Egli. (2018) Definitive urine drug testing in office-based opioid treatment: a literature review. Critical Reviews in Toxicology 48:10, pages 815-838.
Read now
Alethea Desrosiers, Weng-Tink Chooi, Norzarina Mohd Zaharim, Imran Ahmad, Mohd Azhar Mohd Yasin, Sharifah Z. Syed Jaapar, Richard S. Schottenfeld, Balasingam Vicknasingam & Marek C. Chawarski. (2016) Emerging Drug Use Trends in Kelantan, Malaysia. Journal of Psychoactive Drugs 48:3, pages 218-226.
Read now

Articles from other publishers (16)

Nicola Man, Scott A. Sisson, Rebecca McKetin, Agata Chrzanowska, Raimondo Bruno, Paul M. Dietze, Olivia Price, Louisa Degenhardt, Daisy Gibbs, Caroline Salom & Amy Peacock. (2022) Trends in methamphetamine use, markets and harms in Australia, 2003–2019. Drug and Alcohol Review 41:5, pages 1041-1052.
Crossref
Christine D. Lukac, Abigail Steinberg, Kristi Papamihali, Amiti Mehta, Kurt Lock & Jane A. Buxton. (2022) Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey. International Journal of Drug Policy 102, pages 103602.
Crossref
Fares Qeadan, Nana Akofua Mensah, Benjamin Tingey, Rona Bern, Tracy Rees, Erin Fanning Madden, Christina A. Porucznik, Kevin English & Trenton Honda. (2021) The association between opioids, environmental, demographic, and socioeconomic indicators and COVID-19 mortality rates in the United States: an ecological study at the county level. Archives of Public Health 79:1.
Crossref
Sharon Weissman, Xueying Yang, Jiajia Zhang, Shujie Chen, Bankole Olatosi & Xiaoming Li. (2021) Using a machine learning approach to explore predictors of healthcare visits as missed opportunities for HIV diagnosis. AIDS 35:Supplement 1, pages S7-S18.
Crossref
Marek C. Chawarski, Kathryn Hawk, E. Jennifer Edelman, Patrick O’Connor, Patricia Owens, Shara Martel, Edouard CoupetJr.Jr., Lauren Whiteside, Judith I. Tsui, Richard Rothman, Ethan Cowan, Lynne Richardson, Michael S. Lyons, David A. Fiellin & Gail D’Onofrio. (2020) Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder. Annals of Emergency Medicine 76:6, pages 782-787.
Crossref
Christopher M. Jones, Natasha Underwood & Wilson M. Compton. (2019) Increases in methamphetamine use among heroin treatment admissions in the United States, 2008–17. Addiction 115:2, pages 347-353.
Crossref
Christopher M Jones, Faraah Bekheet, Ju Nyeong Park & G Caleb Alexander. (2020) The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms. Epidemiologic Reviews 42:1, pages 154-166.
Crossref
Michael Farrell, Natasha K Martin, Emily Stockings, Annick Bórquez, Javier A Cepeda, Louisa Degenhardt, Robert Ali, Lucy Thi Tran, Jürgen Rehm, Marta Torrens, Steve Shoptaw & Rebecca McKetin. (2019) Responding to global stimulant use: challenges and opportunities. The Lancet 394:10209, pages 1652-1667.
Crossref
Brittany B. Dennis, Pavel S. Roshanov, Leen Naji, Monica Bawor, James Paul, Carolyn Plater, Guillaume Pare, Andrew Worster, Michael Varenbut, Jeff Daiter, David C. Marsh, Dipika Desai, Zainab Samaan & Lehana Thabane. (2015) Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria. Trials 16:1.
Crossref
Kevin A. Sevarino & Bryan C. Shelby. 2015. Psychiatry. Psychiatry 1561 1614 .
Rebecca M. SchwartzKathleen M. WeberGabrielle E. SchechterNina C. ConnorsYolene GousseMary A. YoungMardge H. Cohen. (2014) Psychosocial Correlates of Gender-Based Violence Among HIV-Infected and HIV-Uninfected Women in Three US Cities. AIDS Patient Care and STDs 28:5, pages 260-267.
Crossref
Mary-Lynn BrechtDiane M. Herbeck. (2014) Pregnancy and Fetal Loss Reported by Methamphetamine-Using Women. Substance Abuse: Research and Treatment 8, pages SART.S14125.
Crossref
Benjamin J. Morasco, Maya E. O'Neil, Jonathan P. Duckart & Linda Ganzini. (2014) Comparison of Health Service Use Among Veterans With Methamphetamine Versus Alcohol Use Disorders. Journal of Addiction Medicine 8:1, pages 47-52.
Crossref
Dikla Shmueli-Blumberg, Lian Hu, Colleen Allen, Michael Frasketi, Li-Tzy Wu & Paul VanVeldhuisen. (2013) The National Drug Abuse Treatment Clinical Trials Network Data Share project: Website design, usage, challenges, and future directions. Clinical Trials 10:6, pages 977-986.
Crossref
Elsa de J. Hernández Fuentes, Bernardo Ng & Irma A. González Hernández. (2013) Methamphetamine and male suicide in the US-Mexico border region. Open Journal of Internal Medicine 03:02, pages 30-33.
Crossref
MEHMET SOFUOGLU. (2012) Commentary on Ling et al. (2012): The PROMETA™ treatment does not reduce methamphetamine use. Addiction 107:2, pages 370-371.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.